IP Library Granted Patent US 10,892,038
Granted Patent B2
US 10,892,038 · App. 15/368,979 · Granted Jan 12, 2021

Method to use gene expression to determine likelihood of clinical outcome of renal cancer

Inventors: Wayne Cowens; Steven Shak (Hillsborough, CA); Audrey Goddard (San Francisco, CA); Dejan Knezevic (Palo Alto, CA); Joffre Baker (Montara, CA); Michael C. Kiefer (Walnut Creek, CA); Tara Maddala (Sunnyvale, CA); Frederick L. Baehner (San Francisco, CA)
Assignee: Genomic Health, Inc.
G16B99/00G01N33/57438G06N7/005C12Q2600/112C12Q2600/118C12Q2600/158
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,892,038
App. No.
15/368,979
Granted
Jan 12, 2021
Kind
B2
Abstract

The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.

Claims (62)

1. A method of analyzing the expression of RNA transcripts of genes in a human renal cancer patient, comprising:

measuring a level of an RNA transcript, in a renal tumor sample from the patient, of a panel of genes consisting of:

(a) a set of genes consisting of one or more genes selected from: YBX1, XIAP, WWOX, VWF, VEGFA, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TYMS, TUSC4, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNFSF12, TNFSF10, TNFRSF11B, TNFRSF10D, TNFRSF10B, TNFAIP6, TMEM47, TM2M27, TLR3, TIMP3, TIMP2, THBS1, TGFBR2, IGF1R, IF127, ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSD11B2, HPN, HPCAL1, HMGB1, HLA-DPB1, HIF1AN, HDAC1, HAVCR1, HADH, GZMA, GSTP1, GSTM3, GSTM1, GRB7, GPX3, GJA1, GFRA1, GCLC, GBP2, GATM, GATA3, FOS, TGFBR1, TGFB2, TGFA, TEK, TCF4, TAP1, TAGLN, TACSTD2, SUCLG1, STK11, STAT5B, STAT5A, STATS, SPRY1, SPARCL1, SPARC, SOD1, SNRK, SNAI1, SMAD4, SMAD2, SLC34A1, SLC22A6, SKIL, SHANKS, SGK1, SFRP1, SEMA3F, SELENBP1, SDPR, SDHA, SCNN1A, FOLR1, FLT4, FLT3LG, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAS, FABP1, ESRRG, ERG, ERCC1, ERBB3, ERBB2, EPHB4, EPHA2, EPAS1, ENPP2, ENPEP, ENG, EMP1, EMCN, ELTD1, EIF2C1, SCN4B, RPTOR, RPS6KB1, RPS6KA1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RGS5, RERGL, RELA, RB1, RASSF1, BARB, RALBP1, RAF1, PTPRG, PTPRB, PTN, PTK2, PTH1R, PTEN, PSMB9, PSMB8, PRSS8, PRPS2, PRKCH, PPP2CA, EGR1, EGLN3, EGFR, EFNB2, EFNB1, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPYS, DPEP1, DLL4, DLC1, DKFZP564O0823, DICER1, DIAPH1, DIABLO, DHPS, DET1, DEFB1, DDC, DCXR, DAPK1, CYR61, CYP3A4, CXCL9, CXCL12, CX3CR1, CX3CL1, PPARG, PPAP2B, PLG, PLAT, PLA2G4C, PIK3CA, PIK3C2B, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFD, PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, NRG1, NPR1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2, NOL3, NFX1, CUL1, CUBN, CTSS, CTSH, CTNNB1, CTNNA1, CTGF, CSF1R, CSF1, CRADD, COL4A2, COL18A1, CLU, CLDN7, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1B, CDKN1A, CDH6, CDH5, CDH16, CDH13, CD4, CD36, CD34, CCR7, CCR4, CCND1, CCL4, CCL2, CAT, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MVP, MUC1, MTOR, MSH3, MSH2, MLST8, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAPK3, MAPK1, MAP4, MAP2K3, MAP2K1, MAL2, MAL, LYZ, LTF, LRP2, LMO2, LDB2, LDB1, LAMA4, KRT7, CASP6, CASP10, CALD1, CA9, CA2, C7, C2 orf40, C13orf15, BUB3, BTRC, BIRC2, BIN1, BGN, BCL2L12, BCL2L1, BCL2, BBC3, BAG1, BAD, ATP6V1B1, ASS1, ARRB1, ARHGDIB, AQP1, APOLD1, APC, ANXA4, ANXA1, ANTXR1, ANGPTL4, ANGPTL3, ANGPT1, ALDOB, KRAS, KL, KITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, JAG1, ITGB1, ITGA7, ITGA6, ITGA4, ITGA3, IQGAP2, INSR, IMPS, IL6ST, IL15, IGFBP6, IGFBP3, IGFBP2, ALDH6A1, ALDH4A1, AKT3, AKT2, AKT1, AIF1, AHR, AGTR1, ADH1B, ADFP, ADD1, ADAMTS5, ADAMTS1, ACE2, ACADSB, ABCG2, ABCC4, ABCC3, ABCC1, ABCB1, ABAT, AAMP, and A2M;

(b) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, VCAN, UBE2T, TPX2, TOP2A, TK1, TIMP1, TGFBI, SQSTM1, SPP1, SPHK1, SLC7A5, SLC2A1, SLC16A3, SLC13A3, SHC1, SFN, SERPINA5, SEMA3C, SAA2, S100A1, RRM2, RPLP1, PTTG1, PTGS2, PLAUR, PF4, PCSK6, MYBL2, MT1X, MMP9, LGALS1, LAMBS, LAMB1, L1CAM, IL8, IL6, ICAM1, HIST1H1D, FN1, F3, F2, ESPL1, EPHB2, EPHB1, ENO2, EIF4EBP1, CXCR4, CXCL1, CTSB, CRP, CP, COL7A1, COL1A1, CHEK1, CENPF, CD82, CD44_s, CCNE1, CCNB1, CCL20, CA12, C3, BUB1, MMP7, MMP14, MKI67, MGST1, MDK, LOX, LMNB1, LIMK1, BIRC5, BIRC3, BCL2A1, AURKA, ANXA2, ALOX5, ADAM8, and ABCC2;

(c) a set of genes consisting of one or more genes selected from: ACE2, ADD1, ALDOB, ANGPTL3, APOLD1, AQP1, NUDT6, CASP10, CAV2, CCL4, CCL5, CCR2, CCR4, CCR7, CD4, CD8A, CEACAM1, CFLAR, CTSS, CX3CL1, CXCL10, CXCL9, CXCR6, DAPK1, DDC, DLC1, C2 orf40, EDNRB, EMCN, EPAS1, FAS, FH, GATA3, GZMA, HLA-DPB1, HSPG2, ICAM2, ICAM3, ID1, IGF1R, IL15, IQGAP2, KLRK1, LDB2, LRP2, LTF, MAP4, ABCC1, NOS3, PIK3C2B, PLA2G4C, PPAP2B, PRCC, PRKCB, PRKCH, PRSS8, PSMB9, PTPRB, RGS5, SDPR, SELE, SGK1, SHANKS, SNRK, TEK, TGFBR2, TIMP3, TMEM27, TSPAN7, UBB, and WWOX; and

(d) a set of consisting of one or more genes selected from: BIRC2, BUB1, CCNB1, ENO2, ITGB1, ITGB5, LAMB1, MMP14, MMP9, PSMA7, RUNX1, SPHK1, SPP1, SQSTM1, TPX2, TUBBA2, and VCAN;

wherein the gene(s) of the sets do not overlap, and wherein one or more of AAMP, RPS23, SDHA, UBB, and RPLP1 is a member of the panel.

2. The method of claim 1 , wherein the renal cancer is renal cell carcinoma (RCC).

3. The method of claim 2 , wherein the RCC is clear cell renal cell carcinoma (ccRCC).

4. The method of claim 1 , wherein the level of the RNA transcripts is measured by quantitative RT-PCR.

5. The method of claim 1 , wherein the renal tumor sample is obtained from a biopsy.

6. The method of claim 1 , wherein the renal tumor sample is paraffin-embedded and fixed.

7. The method of claim 1 , wherein one or more angiogenesis genes selected from: ADD1, ANGPTL3, APOLD1, CEACAM1, EDNRB, EMCN, ENG, EPAS1, FLT1, JAG1, KDR, KT, LDB2, NOS3, NUDT6, PPAP2B, PRKCH, PTPRB, RGS5, SHANK3, SNRK, TEK, ICAM2, and VCAM1;

one or more immune response genes selected from: CCL5, CCR7, CD8A, CX3CL1, CXCL10, CXCL9, HLA-DPB1, IL6, IL8, and SPP1;

a transport gene selected from AQP1, SGK1, and both AQP1 and SGK1;

one or more cell adhesion/extracellular matrix genes selected from: ITGB1, A2M, ITGB5, LAMB1, LOX, MMP14, TGFBR2, TIMP3, and TSPAN7;

one or more cell cycle genes selected from: BUB1, C13 orf15, CCNB1, PTTG1, TPX2, LMNB1, and TUBB2A; and/or

CASP10

is a member of the panel of genes.

8. A method of analyzing the expression of RNA transcripts of genes in a human renal cancer patient, comprising:

measuring a level of an RNA transcript, in a renal tumor sample from the patient, of a panel of genes consisting of:

(a) a set of genes consisting of one or more genes selected from: YBX1, XIAP, WWOX, VWF, VEGFA, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TYMS, TUSC4, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNFSF12, TNFSF10, TNFRSF11B, TNFRSF10D, TNFRSF10B, TNFAIP6, TMEM47, TMEM27, TLR3, TIMP3, TIMP2, THBS1, TGFBR2, IGF1R, IFI27, ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSD11B2, HPN, HPCAL1, HMGB1, HLA-DPB1, HIF1AN, HDAC1, HAVCR1, HADH, GZMA, GSTP1, GSTM3, GSTM1, GRB7, GPX3, GJA1, GFRA1, GCLC, GBP2, GATM, GATA3, FOS, TGFBR1, TGFB2, TGFA, TEK, TCF4, TAP1, TAGLN, TACSTD2, SUCLG1, STK11, STAT5B, STAT5A, STATS, SPRY1, SPARCL1, SPARC, SOD1, SNRK, SNAI1, SMAD4, SMAD2, SLC34A1, SLC22A6, SKIL, SHANKS, SGK1, SFRP1, SEMA3F, SELENBP1, SDPR, SDHA, SCNN1A, FOLR1, FLT4, FLT3LG, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAS, FABP1, ESRRG, ERG, ERCC1, ERBB3, ERBB2, EPHB4, EPHA2, EPAS1, ENPP2, ENPEP, ENG, EMP1, EMCN, ELTD1, EIF2C1, SCN4B, RPTOR, RPS6KB1, RPS6KA1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RGS5, RERGL, RELA, RB1, RASSF1, BARB, RALBP1, RAF1, PTPRG, PTPRB, PTN, PTK2, PTH1R, PTEN, PSMB9, PSMB8, PRSS8, PRPS2, PRKCH, PPP2CA, EGR1, EGLN3, EGFR, EFNB2, EFNB1, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPYS, DPEP1, DLL4, DLC1, DKFZP56400823, DICER1, DIAPH1, DIABLO, DHPS, DET1, DEFB1, DDC, DCXR, DAPK1, CYR61, CYP3A4, CXCL9, CXCL12, CX3CR1, CX3CL1, PPARG, PPAP2B, PLG, PLAT, PLA2G4C, PIK3CA, PIK3C2B, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFD, PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, NRG1, NPR1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2, NOL3, NFX1, CUL1, CUBN, CTSS, CTSH, CTNNB1, CTNNA1, CTGF, CSF1R, CSF1, CRADD, COL4A2, COL18A1, CLU, CLDN7, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1B, CDKN1A, CDH6, CDH5, CDH16, CDH13, CD4, CD36, CD34, CCR7, CCR4, CCND1, CCL4, CCL2, CAT, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MVP, MUC1, MTOR, MSH3, MSH2, MLST8, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAPK3, MAPK1, MAP4, MAP2K3, MAP2K1, MAL2, MAL, LYZ, LTF, LRP2, LMO2, LDB2, LDB1, LAMA 4, KRT7, CASP6, CASP10, CALD1, CA9, CA2, C7, C2 orf40, C13 orf15, BUB3, BTRC, BIRC2, BIN1, BGN, BCL2L12, BCL2L1, BCL2, BBC3, BAG1, BAD, ATP6V1B1, ASS1, ARRB1, ARHGDIB, AQP1, APOLD1, APC, ANXA4, ANXA1, ANTXR1, ANGPTL4, ANGPTL3, ANGPT1, ALDOB, KRAS, KTKITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, JAG1, ITGB1, ITGA7, ITGA6, ITGA4, ITGA3, IQGAP2, INSR, IMPS, IL6ST, IL15, IGFBP6, IGFBP3, IGFBP2, ALDH6A1, ALDH4A1, AKT3, AKT2, AKT1, AIF1, AHR, AGTR1, ADH1B, ADFP, ADD1, ADAMTS5, ADAMTS1, ACE2, ACADSB, ABCG2, ABCC4, ABCC3, ABCC1, ABCB1, ABAT, AAMP, and A2M;

(b) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, VCAN, UBE2T, TPX2, TOP2A, TK1, TIMP1, TGFBI, SQSTM1, SPP1, SPHK1, SLC7A5, SLC2A1, SLC16A3, SLC13A3, SHC1, SFN, SERPINA5, SEMA3C, SAA2, S100A1, RRM2, RPLP1, PTTG1, PTGS2, PLAUR, PF4, PCSK6, MYBL2, MT1X, MMP9, LGALS1, LAMB3, LAMB1, L1CAM, IL8, IL6, ICAM1, HIST1H1D, FN1, F3, F2, ESPL1, EPHB2, EPHB1, ENO2, EIF4EBP1, CXCR4, CXCL1, CTSB, CRP, CP, COL7A1, COL1A1, CHEK1, CENPF, CD82, CD44_s, CCNE1, CCNB1, CCL20, CA12, C3, BUB1, MMP7, MMP14, MKI67, MGST1, MDK, LOX, LMNB1, LIMK1, BIRC5, BIRC3, BCL2A1, AURKA, ANXA2, ALOX5, ADAM8, and ABCC2;

(c) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, UBE2T, TSPAN8, TPX2, TOP2A, TK1, TIMP1, TGFBI, SPP1, SLC7A5, SLC16A3, SFN, SEMA3C, SELL, SAA2, RRM2, RPLP1, RAD51, PTTG1, PTGS2, PTGIS, PLAUR, PF4, PDGFRA, PCSK6, NNMT, NME2, MYBL2, MT1X, MMP9, MMP7, MMP14, LAMA 3, L1CAM, ISG20, IL8, IL6, IGF1 ICAM1, HIST1H1D, GPX2, FN1, FAP, F3, F2, ESPL1, EPB41L3, ENO2, EIF4EBP1, E2F1, DCN, CXCR6, CXCR5, CXCR4, CXCL1, CTSB, CRP, CP, COL7A1, COL1A1, CHEK2, CHEK1, CENPF, CD82, CD44_s, CCNE2_2, CCNB1, MKI67, MGST1, MDK, MDH2, LRRC2, LOX, LMNB1, LIMK1, LAPTM5, LAMB3, LAMB1, CCL20, CA12, C3, BUB1, BIRC5, BCL2A1, AURKA, APOL1, ANXA2, ADAM8, and ABCC2;

(d) a set of genes consisting of one or more genes selected from: YBX1, XIAP, WWOX, WISP1, VWF, VEGF, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TYMS, TUSC4, TUSC2, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNIP2, TNFSF12, TNFSF10, TNFRSF11B, TNFRSF10D, TNFRSF10B, TNFAIP6, TNF, TMEM47, TMEM27, TLR3, TIMP3, TIMP2, THBS1, TGFBR2, IL7, IL6ST, IL15, IGFBP6, IGFBP3, IGF1R, ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSD11B2, HPN, HPCAL1, HNRNPAB, HMGB1, HLA-DPB1, HIF1AN, HIF1A, HGF, HDAC1, HAVCR1, HADH, GSTT1, GSTP1, GSTM3, GSTM1, GRB7, GRB14, GPX3, GNAS, GJA1, GFRA1, TGFBR1, TGFB2, TGFB1, TGFA, TEK, TCF4, TAP1, TAGLN, TACSTD2, SUCLG1, STK11, STAT5B, STAT5A, STATS, STAT1, SPRY1, SPAST, SPARCL1, SPARC, SOD1, SNRK, SNAI1, SMAD4, SMAD2, SLC9A1, SLC34A1, SLC22A6, SKIL, SIRPA, SHANKS, SGK1, SFRP1, SEMA3F, SELPLG, SELENBP1, GCLM, GCLC, GBP2, GATM, GATA3, FOS, FOLR1, FLT4, FLT3LG, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAS, ESRRG, ERG, ERCC1, ERBB4, ERBB3, ERBB2, EPHB4, EPHA2, ENPP2, ENPEP, ENG, EMP1, SDPR, SDHA, SCNN1A, SCN4B, S100A2, RPTOR, RPS6KB1, RPS6KA1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RHEB, RGS5, RERGL, RB1, RASSF1, BARB, RALBP1, RAF1, RAC1, PTPRG, PTPRB, PTN, PTK2, PTH1R, PTEN, PSMB9, PSMB8, PSMA7, PRSS8, EMCN, ELTD1, EIF2C1, EGR1, EGLN3, EGFR, EGF, EFNB2, EFNB1, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPYS, DPEP1, DLL4, DLC1, DKFZP56400823, DICER1, DIAPH1, DIABLO, DHPS, DET1, DEFB1, DDC, DAPK1, CYR61, CXCL12, CX3CR1, CX3CL1, CUL1, CUBN, PRPS2, PRKCH, PRKCD, PPP2CA, PPARG, PPAP2B, PLG, PLAT, PLA2G4C, PIK3CA, PIK3C2B, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFD PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, NPRP1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2A, NOL3, CTSS, CTSH, CTNNB1, CTNNA1, CTGF, CSF2RA, CSF1R, CSF1, CRADD, COL4A2, COL4A1, COL18A1, CLU, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1A, CDH6, CDH5, CDH2, CDH16, CDH13, CDC25B, CD4, CD36, CD34, CD24, CD14, CCND1, CCL4, CCL2, CAT, CASP10, CALD1, NFX1, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MX1, MVP, MUC1, MTOR, MSH3, MSH2, MMP11, MLST8, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAPK3, MAPK1, MAP4, MAP2K3, MAP2K1, MAL2, MAL, LYZ, LTF, LRP2, LMO2, LDB2, LDB1, LAMA 4, CACNA2D1, CA9, CA2, C3AR1, C2 orf40, C1QA, C13 orf15, BUB3, BTRC, BIRC2, BIN1, BGN, BCL2L1, BCL2, BAX, BAK1, BAG1, ATP6V1B1, ATP1A1, ASS1, ARRB1, ARHGDIB, AQP1, APOLD1, APC, ANXA4, ANXA1, ANTXR1, ANGPTL4, ANGPTL3, ANGPTL2, ANGPT2, ANGPT1, ALDOB, ALDH6A1, KRT7, KRAS, KIT, KITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, JAG1, ITGB5, ITGB1, ITGA7, ITGA6, ITGA5, ITGA4, ITGA3, IQGAP2, INSR, IMP3, ALDH4A1, AKT3, AKT2, AKT1, AIF1, AHR, AGTR1, ADH1B, ADD1, ADAMTS5, ADAM17, ACE2, ACADSB, ABCG2, ABCC4, ABCC3, ABCC2, ABCB1, ABAT, AAMP, and A2M;

(e) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, UBE2T, TYMP, TPX2, TOP2A, TNFSF13B, TK1, TGFBI, STAT1, SQSTM1, SPP1, SLC7A5, SLC16A3, SLC13A3, SFN, SEMA3C, SAA2, S100A1, RRM2, RPLP1, RAD51, PTTG1, PSMB9, PSMB8, PRKCB, PDCD1, PCSK6, PCNA, NME2, MYBL2, MMP9, MMP14, MKI67, HPD, HIST1H1D, HGD, GZMA, GPX2, GPX1, FCGR3A, FASLG, FABP1, F2, ESPL1, E2F1, CXCR6, CXCR5, CXCL9, CXCL10, CXCL1, CTSD, CTSB, CRP, CP, CHEK2, CHEK1, CENPF, CD8A, CD82, CD70, CCNE1, CCNB1, CCL5, CCL20, CAV2, CA12, C3, C1QB, MGST1, MET, MDK, MDH2, MCM2, LOX, LMNB1, LIMK1, LAPTM5, LAMBS, L1CAM, KLRK1, ITGB2, IL8, IL6, ICAM1, HSPA8, BUB1, BRCA1, BIRC5, BIRC3, AURKA, ATP5E, APOL1, APOE, APOC1, ANXA2, ANGPTL3, AMACR, ALOX5, ALDH4A1, ADAMS, and ABCC2;

(f) a set of genes consisting of one or more genes selected from: ZHX2, YBX1, XPNPEP2, XIAP, WISP1, VWF, VHL, VEGFA, VCAN, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TUSC4, TUSC2, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNIP2, TNFSF12, TNFRSF11B, TNFRSF10D, TNFR5F10C, TNFRSF10B, TNFAIP6, TNFAIP3, TNF, TMEM47, TMEM27, TIMP3, ITGA4, ITGA3, IQGAP2, INSR, INHBA, IMP3, IL6ST, IL1B, IL15, IL10, IGFBP6, IGFBP5, IGFBP2, IGF2, IGF1R ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSPA1A, HSP90AB1, HSD11B2, HPCAL1, HNRNPAB, HMGB1, HIF1AN, HIF1A, HGF, HDAC1, HADH, GSTP1, TIMP2, THBS1, THBD, TGFBR2, TGFBR1, TGFB2, TGFB1, TGFA, TEK TDGF1, TCF4, TAGLN, TACSTD2, SUCLG1, STK11, STC2, STAT5B, STAT5A, STATS, SPRY1, SPAST, SPARCL1, SPARC, SNRK, SNAI1, SMAD4, SMAD2, SLC9A1, SLC34A1, SKIL, SHC1, SHANKS, SGK1, SFRP1, GSTM3, GSTM1, GRB7, GRB14, GPC3, GNAS, GMNN, GJA1, GCLM, GCLC, GATM, GATA3, GAS2, GADD45B, FST, FOS, FOLR1, FLT4, FLT3LG, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAP, ESRRG, ERG, SERPINE1, SEMA3F, SELENBP1, SELE, SDPR, SDHA, SCNN1A, SCN4B, S100A2, RUNX1, RRM1, RPTOR, RPS6KB1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RHEB, RGS5, RERGL, RELA, RB1, RASSF1, RARB, RALBP1, RAF1, RAC1, PXDN, PTPRG, PTPRB, PTN, ERCC4, ERCC1, ERBB4, ERBB2, EPHB4, EPHA2, EPAS1, ENPP2, ENPEP, ENO2, ENG, EMP1, EMCN, ELTD1, EIF2C1, EGR1, EGLN3, EGF, EFNB2, EFNB1, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPEP1, DLL4, DLC1, DKFZP564O0823, DICER1, DIAPH1, DIABLO, DHPS, PTK2, PTH1R, PTEN, PSMA7, PRPS2, PROM2, PRKCH, PRKCD, PPP2CA, PPARG, PPAP2B, PMP22, PLG, PLAT, PLA2G4C, PIK3CA PIK3C2B, PI3K, PGF, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFRA, PDGFD, PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, DET1, DEFB1, DAPK1, DAG1, CYR61, CXCL12, CX3CR1, CX3CL1, CUL1, CUBN, CTSL1, CTNNB1, CTNNA1, CTGF, CSF1, CRADD, COL5A2, COL4A2, COL4A1, COL1A2, COL18A1, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1B, CDKN1A, CDK4, CDH5, CDH16, CDH13, CD99, CD44_1, CD36, CD34, NPR1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2, NOL3, NFX1, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MX1, MVP, MUC1, MTOR, MT1X, MSH3, MMP2, MMP11, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAPK3, MAPK1, MAP4, MAP2K3, MAP2K1, CD14, CCND1, CCL2, CAT, CASP10, CALD1, CACNA2D1, CA9, CA2, C7, C3AR1, C, C2 orf40, C13 orf15, BUB3, BTRC, BNIP3, BIRC2, BGN, BCL2L1, BCL2, BAG1, AXL, ATP6V1B1, ASS1, ARRB1, ARHGDIB, ARF1, AREG, AQP1, APOLD1, APC, APAF1, ANXA1, ANTXR1, ANGPTL4, MAL, LRP2, LMO2, LDB2, LDB1, LAMB1, LAMA 4, KRT7, KRAS, KL, KITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, JAG1, ITGB5, ITGB3, ITGB1, ITGA7, ITGA6, ITGA5, ANGPTL2, ANGPT2, ANGPT1, ALDOB, ALDH6A1, AKT3, AKT2, AKT1, AHR, AGTR1, ADH1B, ADD1, ADAMTS9, ADAMTS5, ADAMTS4, ADAMTS2, ADAMTS1, ADAM17, ACADSB, ABCG2, ABCC4, AAMP, and A2M;

(g) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, UBE2T, TYMP, TSPAN8, TPX2, TOP2A, TNFSF13B, TK1, TIMP1, SPP1, SPHK1, SLC7A5, SLC2A1, SLC13A3, SHC1, SFN, SERPINE1, SERPINA5, SEMA3C, SELL, SAA2, RRM2, RPLP1, RND3, RAD51, PTTG1, PTGS2, PRKCB, PRKCA, PLAUR, KRT19, ITGB4, ISG20, IL8, IL6, ICAM1, HSPA8, HIST1H1D, GPX1, FZD2, FN1, FCGR3A, FCER1G, FAP, F3, F2, ESPL1, EPHB2, EPHB1, EPB41L3, ENO2, EIF4EBP1, E2F1, CXCR6, CXCR4, CXCL1, CTSB, CRP, CP, COL7A1, COL1A1, CHEK2, CHEK1, CENPF, PLAU, PF4, PDCD1, PCSK6, PCNA, NNMT, NME2, MYBL2, MT1X, MMP9, MMP7, MMP14, MKI67, MGST1, MET, MDK, MCM2, LRRC2, LOX, LMNB1, LIMK1, LGALS9, LGALS1, LAPTM5, LAMBS, L1CAM, CD82, CD68, CD44_S, CCNE2_2, CCNE1, CCNB1, CCL5, CCL20, CAV2, CA12, C3, C1QB, BUB1, BRCA1, BIRC5, BIRC3, BCL2A1, AURKA, ATAD2, APOL1, APOC1, ANXA2, ALOX5, ADAMS, and ABCC2;

(h) a set of genes consisting of one or more genes selected from: YBX1, XIAP, WWOX, WISP1, VWF, VHL, VEGFA, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TYMS, TUSC4, TUSC2, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNFSF12, TNFSF10, TNFRSF11B, TNFRSF10D, TNFRSF10B, TNFAIP6, TMEM47, TMEM27, TLR3, TIMP3, TIMP2, THBS1, TGFBR2, TGFBR1, TGFB2, IGF2, IGF1R, ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSP90AB1, HSD11B2, HPN, HPCAL1, HMGB1, HLA-DPB1, HIF1AN, HDAC1, HAVCR1, HADH, GSTT1, GSTP1, GSTM3, GSTM1, GRB7, GPX3, GPC3, GJA1, GFRA1, GCLC, GATM, GATA3, GADD45B, FOS, FOLR1, FLT4, FLT3LG, TGFB1, TGFA, TEK, TCF4, TAGLN, TACSTD2, SUCLG1, STK11, STAT5B, STAT5A, STATS, SPRY1, SPAST, SPARCL1, SOD1, SNRK, SNAI1, SMAD4, SMAD2, SLC34A1, SLC22A6, SKIL, SHANKS, SGK1, SFRP1, SEMA3F, SELENBP1, SDPR, SDHA, SCNN1A, SCN4B, S100A2, RPTOR, RPS6KB1, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAS, ESRRG, ERG, ERCC4, ERCC1, ERBB4, ERBB3, ERBB2, EPHB4, EPHA2, EPAS1, ENPP2, ENPEP, ENG, EMP1, EMCN, ELTD1, EIF2C1, EGR1, EGLN3, EGFR, EFNB2, EFNB1, RPS6KA1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RHEB, RGS5, RERGL, RELA, RB1, RASSF1, BARB, RALBP1, RAF1, RAC1, PTPRG, PTPRB, PTN, PTK2, PTH1R, PTEN, PSMA7, PRSS8, PRKCH, PRKCD, PPP2CA, PPARG, PPAP2B, PMP22, PLG, PLAT, PLA2G4C, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPYS, DPEP1, DLL4, DLC1, DKFZP56400823, DICER1, DIAPH1, DIABLO, DHPS, DET1, DEFB1, DDC, DCXR, DAPK1, CYR61, CYP3A4, CYP2C8_21, CXCL12, CX3CR1, CX3CL1, CUL1, CUBN, CTSH, CTNNB1, CTNNA1, CTGF, CSF1R, CSF1, CRADD, PIK3CA, PIK3C2B, PGF, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFD, PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, NRG1, NPR1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2, NOL3, NFX1, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MVP, COL4A1, COL18A1, CLU, CLDN7, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1B, CDKN1A, CDH6, CDH5, CDH2, CDH16, CDH13, CD36, CD34, CD24, CCND1, CCL2, CAT, CASP10, CALD1, CACNA2D1, CA2, C7, C2 orf40, C13 orf15, BUB3, BTRC, BNIP3, BIRC2, BIN1, BGN, BCL2L12, MTOR, MSH3, MSH2, MMP2, MMP11, MLST8, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAP2K3, MAP2K1, MAL2, MAL, LTF, LRP2, LMO2, LDB2, LDB1, LAMA 4, KRT7, KRAS, KL, KITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, BCL2L1, BCL2, BAG1, BAD, AXL, ATP6V1B1, ASS1, ARRB1, ARHGFIB, ARF1, AQP1, APOLD1, APC, APAF1, ANXA4, ANXA1, ANTXR1, ANGPTL4, ANGPTL3, ANGPTL2, ANGPT2, ANGPT1, ALDOB, ALDH6A1, ALDH4A1, AKT3, AKT2, AKT1, AHR, AGTR1, AGT, ADH6, ADH1B, ADFP, JAG1, ITGB5, ITGB3, ITGB1, ITGA7, ITGA6, ITGA5, ITGA4, ITGA3, IQGAP2, INSR, IMPS, IL6ST, IL15, IGFBP6, ADD1, ADAMTS9, ADMATS5, ADAMTS1, ADAM17, ACE2, ACADSB, ABCG2, ABCC4, ABCC3, ABCC1, ABCB1, ABAT, AAMP, and A2M;

(i) a set of genes consisting of one or more genes selected from: TUBB2A, TPX2, TK1, SPHK1, SLC7A5, SILV, SELE, PLAU, MMP9, MMP7, MMP14, LAMB1, IL8, IL6, HSP1A1, GSTP1, GRB14, GMNN, ENO2, CCNB1, BUB1, BAG2, and ADAMTS1; and

(j) a set of genes consisting of one or more genes selected from: VWF, VCAM1, UBA3, TUSC4, TSPAN7, TSC1, TSMB10, TMEM47, TMEM27, TLR3, TIMP3, TGFBR2, TGFB2, TGFA, TEK, TCF4, STAT5A, SPRY1, SPARCL1, SOD1, SNRK, SMAD2, SLC22A6, SIRPA, SHANKS, SGK1, SELENBP1, SCN4B, ROCK1, RHOB, RGS5, RERGL, RB1, RASSF1, HMGB1, HLA-DPB1, HADH, GSTM1, GPX2, GJA1, GATM, GATA3, FOLR1, FLT4, FLT1, FHL1, FHIT, FAS, ERBB3, EPHA2, EPAS1, ENPEP, ENG, EMCN, EIF2C1, EGLN3, EFNB2, EFNB1, EDNRB, EDN1, DPYS, DKFZP56200823, DHPS, DAPK1, CYP2C8_21, CYP2C8_2, CX3CR1, CUBN, PTPRB, PTK2, PTHR1, PRSS8, PRKCH, PPAP2B, PLA2G4C, PIK3C2B, PFKP, PECAM1, PDGFD, PDGFC, PDFGB, PCSK6, PCK1, PCCA, PARD6A, NUDT6, NRG1, NOS3, NOS2, NFX1, MYH11, MYC, MUC1, MIF, MICA, MGMT, MAP2K1, LMO2, LDB2, KITLG, KDR, ITGB1, ITGA7, CRADD, CLDN10, CFLAR, CEACAM1, CDKN2A, CDKN1B, CDH5, CDH13, CD99, CD36, CD34, CD247, CCND1, CAT, CASP6, CALD1, CA9, C13 orf15, BUB3, BIN1, BCL2L1, BCL2, AXL, ATP6V1B1, ARRB1, ARHGDIB, AQP1, APOLD1, APC, ANXA5, ANXA4, ANXA1, ANGPTL7, ANGPTL4, ANGPT1, ITGA6, ITGA4, INSR, IMPS, IL6ST, IL15, IFI27, HYAL2, HYAL1, HPN, HPCAL1, ALDOB, ALDH4A1, AGTR1, ADH6, ADFP, ADD1, ABCG2, ABCC3, ABCC1, ABAT, and A2M;

wherein the gene(s) of the sets do not overlap.

9. The method of claim 8 , wherein the renal cancer is renal cell carcinoma (RCC).

10. The method of claim 9 , wherein the RCC is clear cell renal cell carcinoma (ccRCC).

11. The method of claim 8 , wherein the level of the RNA transcripts is measured by quantitative RT-PCR.

12. The method of claim 8 , wherein the renal tumor sample is obtained from a biopsy.

13. The method of claim 8 , wherein the renal tumor sample is paraffin-embedded and fixed.

14. The method of claim 8 , wherein one or more of AAMP, ARF1, ATP5E, EEF1A1, GPX1, RPS23, SDHA, UBB, and RPLP1 is a member of the panel.

15. The method of claim 8 , wherein one or more angiogenesis genes selected from: ADD1, ANGPTL3, APOLD1, CEACAM1, EDNRB, EMCN, ENG, EPAS1, FLT1, JAG1, KDR, KL, LDB2, NOS3, NUDT6, PPAP2B, PRKCH, PTPRB, RGS5, SHANK3, SNRK, TEK, ICAM2, and VCAM1;

one or more immune response genes selected from: CCL5, CCR7, CD8A, CX3CL1, CXCL10, CXCL9, HLA-DPB1, IL6, IL8, and SPP1;

a transport gene selected from: AQP1, SGK1, and both AQP1 and SGK1;

one or more cell adhesion/extracellular matrix genes selected from: ITGB1, A2M, ITGB5, LAMB1, LOX, MMP14, TGFBR2, TIMP3, and TSPAN7;

one or more cell cycle genes selected from: BUB1, C13 orf15, CCNB1, PTTG1, TPX2, LMNB1, and TUBB2A; and/or CASP10 is a member of the panel.

16. A method of analyzing the expression of RNA transcripts of genes in a human renal cancer patient, comprising:

measuring a level of an RNA transcript, in a renal tumor sample from the patient, of a panel of genes consisting of:

(a) a set of genes consisting of one or more genes selected from: YBX1, XIAP, WWOX, VWF, VEGFA, VCAM1, USP34, UMOD, UGCG, UBB, UBA3, TYMS, TUSC4, TSPAN7, TSC2, TSC1, TP53, TOP2B, TNFSF12, TNFSF10, TNFRSF11B, TNFRSF10D, TNFRSF10B, TNFAIP6, TMEM47, TM2M27, TLR3, TIMP3, TIMP2, THBS1, TGFBR2, IGF1R, IFI27, ID3, ID2, ID1, ICAM2, HYAL2, HYAL1, HSPG2, HSD11B2, HPN, HPCAL1, HMGB1, HLA-DPB1, HIF1AN, HDAC1, HAVCR1, HADH, GZMA, GSTP1, GSTM3, GSTM1, GRB7, GPX3, GJA1, GFRA1, GCLC, GBP2, GATM, GATA3, FOS, TGFBR1, TGFB2, TGFA, TEK, TCF4, TAP1, TAGLN, TACSTD2, SUCLG1, STK11, STAT5B, STAT5A, STATS, SPRY1, SPARCL1, SPARC, SOD1, SNRK, SNAI1, SMAD4, SMAD2, SLC34A1, SLC22A6, SKIL, SHANKS, SGK1, SFRP1, SEMA3F, SELENBP1, SDPR, SDHA, SCNN1A, FOLR1, FLT4, FLT3LG, FLT1, FILIP1, FIGF, FHL1, FHIT, FH, FGFR2, FGFR1, FGF2, FGF1, FDPS, FBXW7, FAS, FABP1, ESRRG, ERG, ERCC1, ERBB3, ERBB2, EPHB4, EPHA2, EPAS1, ENPP2, ENPEP, ENG, EMP1, EMCN, ELTD1, EIF2C1, SCN4B, RPTOR, RPS6KB1, RPS6KA1, RPS23, ROCK2, ROCK1, RIPK1, RHOC, RHOB, RHOA, RGS5, RERGL, RELA, RB1, RASSF1, BARB, RALBP1, RAF1, PTPRG, PTPRB, PTN, PTK2, PTH1R, PTEN, PSMB9, PSMB8, PRSS8, PRPS2, PRKCH, PPP2CA, EGR1, EGLN3, EGFR, EFNB2, EFNB1, EEF1A1, EDNRB, EDN2, EDN1, EBAG9, DUSP1, DPYS, DPEP1, DLL4, DLC1, DKFZP56400823, DICER1, DIAPH1, DIABLO, DHPS, DET1, DEFB1, DDC, DCXR, DAPK1, CYR61, CYP3A4, CXCL9, CXCL12, CX3CR1, CX3CL1, PPARG, PPAP2B, PLG, PLAT, PLA2G4C, PIK3CA, PIK3C2B, PFKP, PECAM1, PDZK3, PDZK1, PDGFRB, PDGFD, PDGFC, PDGFB, PDGFA, PCK1, PCCA, PARD6A, PAK1, PAH, OGG1, NUDT6, NRG1, NPR1, NPM1, NOTCH3, NOTCH2, NOTCH1, NOS3, NOS2, NOL3, NFX1, CUL1, CUBN, CTSS, CTSH, CTNNB1, CTNNA1, CTGF, CSF1R, CSF1, CRADD, COL4A2, COL18A1, CLU, CLDN7, CLDN10, CLCNKB, CFLAR, CEACAM1, CDKN1B, CDKN1A, CDH6, CDH5, CDH16, CDH13, CD4, CD36, CD34, CCR7, CCR4, CCND1, CCL4, CCL2, CAT, NFKB1, NFATC2, NFAT5, MYRIP, MYH11, MYC, MVP, MUC1, MTOR, MSH3, MSH2, MLST8, MIF, MICA, MGMT, MCM3, MCAM, MARCKS, MAPK3, MAPK1, MAP4, MAP2K3, MAP2K1, MAL2, MAL, LYZ, LTF, LRP2, LMO2, LDB2, LDB1, LAMA 4, KRT7, CASP6, CASP10, CALD1, CA9, CA2, C7, C2 orf40, C13 orf15, BUB3, BTRC, BIRC2, BIN1, BGN, BCL2L12, BCL2L1, BCL2, BBC3, BAG1, BAD, ATP6V1B1, ASS1, ARRB1, ARHGDIB, AQP1, APOLD1, APC, ANXA4, ANXA1, ANTXR1, ANGPTL4, ANGPTL3, ANGPT1, ALDOB, KRAS, KL, KITLG, KIT, KDR, KCNJ15, KAT5, JUP, JUN, JAG1, ITGB1, ITGA7, ITGA6, ITGA4, ITGA3, IQGAP2, INSR, IMPS, IL6ST, IL15, IGFBP6, IGFBP3, IGFBP2, ALDH6A1, ALDH4A1, AKT3, AKT2, AKT1, AIF1, AHR, AGTR1, ADH1B, ADFP, ADD1, ADAMTS5, ADAMTS1, ACE2, ACADSB, ABCG2, ABCC4, ABCC3, ABCC1, ABCB1, ABAT, AAMP, and A2M;

(b) a set of genes consisting of one or more genes selected from: WT1, VTN, VDR, VCAN, UBE2T, TPX2, TOP2A, TK1, TIMP1, TGFBI, SQSTM1, SPP1, SPHK1, SLC7A5, SLC2A1, SLC16A3, SLC13A3, SHC1, SFN, SERPINA5, SEMA3C, SAA2, S100A1, RRM2, RPLP1, PTTG1, PTGS2, PLAUR, PF4, PCSK6, MYBL2, MT1X, MMP9, LGALS1, LAMBS, LAMB1, L1CAM, IL8, IL6, ICAM1, HIST1H1D, FN1, F3, F2, ESPL1, EPHB2, EPHB1, ENO2, EIF4EBP1, CXCR4, CXCL1, CTSB, CRP, CP, COL7A1, COL1A1, CHEK1, CENPF, CD82, CD44_s, CCNE1, CCNB1, CCL20, CA12, C3, BUB1, MMP7, MMP14, MKI67, MGST1, MDK, LOX, LMNB1, LIMK1, BIRC5, BIRC3, BCL2A1, AURKA, ANXA2, ALOX5, ADAM8, and ABCC2;

(c) a set of genes consisting of one or more genes selected from: ACE2, ADD1, ALDOB, ANGPTL3, APOLD1, AQP1, NUDT6, CASP10, CAV2, CCL4, CCL5, CCR2, CCR4, CCR7, CD4, CD8A, CEACAM1, CFLAR, CTSS, CX3CL1, CXCL10, CXCL9, CXCR6, DAPK1, DDC, DLC1, C2 orf40, EDNRB, EMCN, EPAS1, FAS, FH, GATA3, GZMA, HLA-DPB1, HSPG2, ICAM2, ICAM3, ID1, IGF1R, IL15, IQGAP2, KL, KLRK1, LDB2, LRP2, LTF, MAP4, ABCC1, NOS3, PIK3C2B, PLA2G4C, PPAP2B, PRCC, PRKCB, PRKCH, PRSS8, PSMB9, PTPRB, RGS5, SDPR, SELE, SGK1, SHANKS, SNRK, TEK, TGFBR2, TIMP3, TMEM27, TSPAN7, UBB, and WWOX; and

(d) a set of genes consisting of one or more genes selected from: BIRC2, BUB1, CCNB1, ENO2, ITGB1, ITGB5, LAMB1, MMP14, MMP9, PSMA7, RUNX1, SPHK1, SPP1, SQSTM1, TPX2, TUBB2A, and VCAN; and

(e) a set of genes consisting of one or more reference genes wherein the set of reference genes is GAPDH, beta-actin, or both of GAPDH and beta-actin;

wherein the gene(s) of the sets do not overlap.

17. The method of claim 16 , wherein the renal cancer is renal cell carcinoma (RCC).

18. The method of claim 17 , wherein the RCC is clear cell renal cell carcinoma (ccRCC).

19. The method of claim 16 , wherein the level of the RNA transcripts is measured by quantitative RT-PCR.

20. The method of claim 16 , wherein the renal tumor sample is obtained from a biopsy.

21. The method of claim 16 , wherein the renal tumor sample is paraffin-embedded and fixed.

22. The method of claim 16 , wherein one or more angiogenesis genes selected from: ADD1, ANGPTL3, APOLD1, CEACAM1, EDNRB, EMCN, ENG, EPAS1, FLT1, JAG1, KDR, KT, LDB2, NOS3, NUDT6, PPAP2B, PRKCH, PTPRB, RGS5, SHANK3, SNRK, TEK, ICAM2, and VCAM1;

one or more immune response genes selected from: CCL5, CCR7, CD8A, CX3CL1, CXCL10, CXCL9, HLA-DPB1, IL6, IL8, and SPP1;

a transport gene selected from: AQP1, SGK1, and both AQP1 and SGK1;

one or more cell adhesion/extracellular matrix genes selected from: ITGB1, A2M, ITGB5, LAMB1, LOX, MMP14, TGFBR2, TIMP3, and TSPAN7;

one or more cell cycle genes selected from: BUB1, C13 orf15, CCNB1, PTTG1, ‘1 PX2, LMNB1, and TUBB2A; and/or

CASP10 is a member of the panel.

Assignments (2)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0380) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: GENOMIC HEALTH, INC.
Reel/Frame 075294/0821 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: GENOMIC HEALTH, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0380 →
Continuity (4)
Continuation 12987023 · Jan 7, 2011
Provisional Application 61294038 · Jan 11, 2010
Provisional Application 61346230 · May 19, 2010
Related Publication 20170121780A1 · May 4, 2017